ORs and CIs for risk of lymphoma after hospitalization for infections in the first year
| Patient group (n) . | Subgroup (n) . | Number hospitalized with infection in first year . | OR . | 95% CI . | |
|---|---|---|---|---|---|
| Patients . | Controls . | ||||
| NHL (1125) | 35 | 105 | 1.35 | 0.91-2.00 | |
| Age dx 2-14 (447) | 20 | 59 | 1.37 | 0.82-2.33 | |
| Age dx 15-40 (678) | 15 | 46 | 1.32 | 0.73-2.39 | |
| B-cell (422) | 19 | 46 | 1.71 | 0.98-2.98 | |
| T-cell (191) | 4 | 21 | 0.75 | 0.25-2.23 | |
| Unclassified NHL (512) | 12 | 38 | 1.27 | 0.66-2.47 | |
| B-cell NHL | Aggressive B-cell (241) | 15 | 30 | 2.11 | 1.11-4.04 |
| Indolent B-cell (80) | 0 | 1 | |||
| NHL dx 1993 and later (691) | 23 | 73 | 1.27 | 0.79-2.06 | |
| HL (1388) | 28 | 82 | 1.38 | 0.89-2.13 | |
| Age dx 2-14 y (230) | 11 | 28 | 1.61 | 0.79-3.31 | |
| Age dx 15-40 y (1158) | 17 | 54 | 1.26 | 0.73-2.19 | |
| Patient group (n) . | Subgroup (n) . | Number hospitalized with infection in first year . | OR . | 95% CI . | |
|---|---|---|---|---|---|
| Patients . | Controls . | ||||
| NHL (1125) | 35 | 105 | 1.35 | 0.91-2.00 | |
| Age dx 2-14 (447) | 20 | 59 | 1.37 | 0.82-2.33 | |
| Age dx 15-40 (678) | 15 | 46 | 1.32 | 0.73-2.39 | |
| B-cell (422) | 19 | 46 | 1.71 | 0.98-2.98 | |
| T-cell (191) | 4 | 21 | 0.75 | 0.25-2.23 | |
| Unclassified NHL (512) | 12 | 38 | 1.27 | 0.66-2.47 | |
| B-cell NHL | Aggressive B-cell (241) | 15 | 30 | 2.11 | 1.11-4.04 |
| Indolent B-cell (80) | 0 | 1 | |||
| NHL dx 1993 and later (691) | 23 | 73 | 1.27 | 0.79-2.06 | |
| HL (1388) | 28 | 82 | 1.38 | 0.89-2.13 | |
| Age dx 2-14 y (230) | 11 | 28 | 1.61 | 0.79-3.31 | |
| Age dx 15-40 y (1158) | 17 | 54 | 1.26 | 0.73-2.19 | |
CI indicates confidence interval; dx, diagnosis; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; and OR, odds ratio.